Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Bionano Genomics, a Nasdaq-listed biotechnology company specializing in genome analysis solutions, announced that its management will present and hold one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The presentation will showcase the company’s advancements in optical genome mapping technolo…